Comparative Expression of CD45RA and HLADR by CD48+ (Normal) and CD48− (GPI-Deficient) Subpopulations of T Cells in Patients With PNH
Patient ID . | T Cells (CD3+)* . | |||
---|---|---|---|---|
CD48+ CD45RA+ % . | CD48− CD45RA+ % . | CD48+ HLADR+ % . | CD48− HLADR+ % . | |
PNH003 | 56 | 74 | 39 | 6 |
PNH007 | 65 | 94 | 29 | 16 |
PNH008 | 37 | 85 | 12 | 3 |
PNH012 | 48 | 87 | 32 | 3 |
PNH019 | 25 | 75 | ND | ND |
PNH022 | 37 | 82 | 24 | 5 |
PNH034 | 44 | 83 | 12 | 6 |
PNH043 | 57 | 89 | 23 | 4 |
PNH055 | 71 | 95 | 11 | 4 |
PNH063 | 20 | 62 | 23 | 17 |
PNH072 | 56 | 93 | ND | ND |
PNH079 | 42 | 72 | 23 | 13 |
PNH087 | 62 | 94 | 16 | 4 |
PNH090 | 61 | 91 | 5 | 1 |
PNH091 | 20 | 62 | 17 | 2 |
Normal range† | ND | NA | <20 | NA |
Patient ID . | T Cells (CD3+)* . | |||
---|---|---|---|---|
CD48+ CD45RA+ % . | CD48− CD45RA+ % . | CD48+ HLADR+ % . | CD48− HLADR+ % . | |
PNH003 | 56 | 74 | 39 | 6 |
PNH007 | 65 | 94 | 29 | 16 |
PNH008 | 37 | 85 | 12 | 3 |
PNH012 | 48 | 87 | 32 | 3 |
PNH019 | 25 | 75 | ND | ND |
PNH022 | 37 | 82 | 24 | 5 |
PNH034 | 44 | 83 | 12 | 6 |
PNH043 | 57 | 89 | 23 | 4 |
PNH055 | 71 | 95 | 11 | 4 |
PNH063 | 20 | 62 | 23 | 17 |
PNH072 | 56 | 93 | ND | ND |
PNH079 | 42 | 72 | 23 | 13 |
PNH087 | 62 | 94 | 16 | 4 |
PNH090 | 61 | 91 | 5 | 1 |
PNH091 | 20 | 62 | 17 | 2 |
Normal range† | ND | NA | <20 | NA |
As determined by three-color flow cytometry using CD48/CD45RA/CD3 and HLA-DR/CD48/CD3 combinations of monoclonal antibodies as described in Materials and Methods section. Values in the table are the percentage of either CD48+ or CD48− cells expressing either CD45RA or HLA-DR determinants.
Abbreviations: ND, not determined; NA, not applicable.
T cells identified on the basis of strong CD3 positivity and low SSC characteristics. Statistical comparisons were made using a pairedt test: Statistically significant differences in expression of CD45RA and HLA-DR were shown between CD48+ and CD48− lymphocytes.
Normal range for HLA-DR expression by T cells derived from analysis of 27 normal adult controls.